Jump to main content
Jump to site search

Issue 5, 2017
Previous Article Next Article

Design, synthesis and biological evaluation of imidazopyridine–propenone conjugates as potent tubulin inhibitors

Author affiliations

Abstract

A library of imidazopyridine–propenone conjugates (8a–8u) were synthesized and evaluated for their antitumor activity against four human cancer cell lines, namely, prostate (DU-145), lung (A549), cervical (Hela) and breast (MCF-7) cancer cell lines. These conjugates showed good to moderate activity against the tested cell lines. Among them, two conjugates (8m and 8q) showed significant antiproliferative activity against the human lung cancer cell line (A549) with IC50 values of 0.86 μM and 0.93 μM, respectively. Flow cytometry analysis revealed that these compounds arrested the cell cycle at the G2/M phase in the human lung cancer cell line (A549), inhibiting tubulin polymerization leading to apoptosis. Further, Hoechst staining, decrease in mitochondrial membrane potential and Annexin V-FITC assay suggested that the cell death was due to apoptosis induction. Overall, the present investigation demonstrated that the synthesized imidazopyridine–propenone conjugates are promising tubulin inhibitors and apoptotic inducers.

Graphical abstract: Design, synthesis and biological evaluation of imidazopyridine–propenone conjugates as potent tubulin inhibitors

Back to tab navigation

Supplementary files

Publication details

The article was received on 25 Jan 2017, accepted on 28 Feb 2017 and first published on 06 Mar 2017


Article type: Research Article
DOI: 10.1039/C7MD00043J
Citation: Med. Chem. Commun., 2017,8, 1000-1006
  •   Request permissions

    Design, synthesis and biological evaluation of imidazopyridine–propenone conjugates as potent tubulin inhibitors

    I. B. Sayeed, V. Lakshma Nayak, M. A. Shareef, N. K. Chouhan and A. Kamal, Med. Chem. Commun., 2017, 8, 1000
    DOI: 10.1039/C7MD00043J

Search articles by author

Spotlight

Advertisements